Literature DB >> 8474429

Production and characterization of antibodies specific for the imidazoline receptor protein.

H Wang1, S Regunathan, D A Ruggiero, D J Reis.   

Abstract

Polyclonal antibodies were raised in rabbits against a 70-kDa ligand-binding protein of the imidazoline receptor purified from solubilized bovine adrenal chromaffin cell membranes by ligand affinity chromatography. The antibodies labeled a single protein (approximately 70 kDa) in Western blots of bovine adrenal chromaffin cell membranes, inhibited 40% of specific [3H]idazoxan binding to imidazoline receptors in chromaffin cell membranes, and specifically immunoprecipitated 75% of all imidazoline-binding activity of solubilized chromaffin cell membrane proteins. The antibodies specifically immunostained heterogeneous subsets of cultured bovine chromaffin cells. They stained subpopulations of chromaffin cells of rat adrenal medulla but not the cells of adrenal cortex. We conclude that the antibodies recognize with high specificity and selectivity a approximately 70-kDa binding protein associated with or representing the imidazoline receptor that is expressed in mammalian species. Highly specific antibodies against the imidazoline receptor protein will permit mapping of the distribution of imidazoline receptors in brain and periphery and also may be useful as probes in cloning genes encoding the imidazoline receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474429

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  4 in total

1.  Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.

Authors:  P V Escribá; R Alemany; M Sastre; G Olmos; A Ozaita; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

2.  Pharmacological and molecular discrimination of brain I2-imidazoline receptor subtypes.

Authors:  G Olmos; R Alemany; J A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

3.  Platelet imidazoline receptors as state marker of depressive symptomatology.

Authors:  John Piletz; Robert Baker; Angelos Halaris
Journal:  J Psychiatr Res       Date:  2006-12-12       Impact factor: 4.791

4.  The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.

Authors:  R Alemany; G Olmos; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.